Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN107200770B details efficient separation of telapristone intermediates. Achieves 99% purity and 65% yield with solvent beating and recycling.
Advanced synthetic route for epirubicin hydrochloride via chiral reduction. Offers high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN103613530B reveals high-yield reduction method for steroidal drug intermediates. Optimized process ensures supply chain stability and cost efficiency.
Novel patent CN102311472B offers chromatography-free Clofarabine synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates.
Advanced resolution method for S-2-aminobutanamide hydrochloride improves yield and purity. Cost-effective levetiracetam intermediate manufacturing via mother liquor recycling.
Patent CN117105909A reveals a mild one-step synthesis for Lasmiditan intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel anhydrous hydrolysis route for trityl olmesartan ensures high purity and yield, offering significant cost reduction in API manufacturing and supply chain stability.
Novel 8-oxa-3-azabicyclo[3.2.1]octane compounds for ATR inhibition. Enhanced solubility and metabolic stability for oncology drug development and supply chain optimization.
Novel asymmetric hydrogenation route for sitagliptin intermediate CN106146340B. High ee value >99%, cost-effective manufacturing, reliable supply chain solution.
Patent CN104987323A details a cost-effective Dabigatran etexilate preparation method, offering significant supply chain stability and purity advantages for global pharmaceutical procurement.
Novel catalytic method ensures >98% purity for Vitamin A intermediates. Reduces purification steps and enhances supply chain stability for global buyers.
Novel copper-catalyzed synthesis of phenanthridone intermediates. High yield, scalable process for pharmaceutical manufacturing. Reliable supply chain partner.
Discover a novel synthesis route for trans-4-Boc-aminocyclohexanecarboxylic acid via patent CN113402428A. Achieve >95% stereoselectivity and streamlined manufacturing for peptide drugs.
Patent CN104447791B reveals a low-cost D-biotin preparation method. Discover supply chain advantages and high-purity manufacturing capabilities for global procurement.
Patent CN115448813B details a manganese-catalyzed route for Crizotinib intermediates. Achieves 95% ee with reduced costs and scalable mild conditions for global supply chains.
Patent CN115417895A reveals a safer microchannel hydrogenation process for cis-propenyl phosphoric acid, offering >97% selectivity and reduced catalyst costs for fosfomycin production.
Patent CN1228448C details a yeast-catalyzed route for (R)-2-halo-1-(substituted phenyl) ethanol, offering significant cost reduction in API manufacturing and superior stereocontrol.
Novel ticagrelor preparation method avoids hazardous chlorinating agents. Water-based steps reduce cost. Reliable supplier for scale-up and high purity.
Patent CN111471077B reveals a novel 2-deoxy-D-ribose derivative route achieving 8:1 beta-selectivity. Discover cost-effective, scalable manufacturing for oncology APIs.
Patent CN111333495A details a mild Eaton reagent method for high-purity benzophenone ketones, offering cost-effective scale-up for oncology drug development.